Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Rosa

Showing results (311-320 of 333) with videos related to

Pageof 34
Sort By:
Critical Care Medicine|February 21, 2025
Society of Critical Care Medicine Guidelines on Family-Centered Care for Adult ICUs: 2024David Y Hwang, Simon J W Oczkowski, Kimberley Lewis, et al.
The European Respiratory Journal|July 10, 2021
Convalescent plasma for COVID-19 in hospitalised patients: an open-label, randomised clinical trialLeo Sekine, Beatriz Arns, Bruna R Fabro, et al.
Critical Care Explorations|June 26, 2025
Unmet Nonmedication Needs After Hospital Discharge and Adverse Outcomes Among Acute Respiratory Failure Survivors in Brazil: A Prospective Feasibility StudySérgio R R Decker, Danielle do A Pereira, Gabriela S Rech, et al.
The American Journal of Cardiology|December 17, 2023
Cardiovascular Safety of Azithromycin in Patients Hospitalized With COVID-19: A Prespecified Pooled Analysis of the COALITION I and COALITION II Randomized Clinical TrialsRemo H M Furtado, Pedro G M Barros E Silva, Henrique A R Fonseca, et al.
Journal of Critical Care|August 3, 2024
Antisense therapy to block the Kallikrein-kinin pathway in COVID-19: The ASKCOV randomized controlled trialFernando G Zampieri, Glauco Adrieno Westphal, Maria Adelaide Dos Santos, et al.
Eclinicalmedicine|May 24, 2023
Rivaroxaban to prevent major clinical outcomes in non-hospitalised patients with COVID-19: the CARE - COALITION VIII randomised clinical trialÁlvaro Avezum, Haliton Alves Oliveira Junior, Precil Diego M M Neves, et al.
Lancet (London, England)|September 8, 2020
Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trialRemo H M Furtado, Otavio Berwanger, Henrique A Fonseca, et al.
JAMA|September 3, 2020
Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical TrialBruno M Tomazini, Israel S Maia, Alexandre B Cavalcanti, et al.
Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition|October 15, 2024
Agreement between the EWGSOP2 and SDOC consensuses for sarcopenia in patients receiving hemodialysis: Findings of a cross sectional analysis from the SARC-HD studyMarvery P Duarte, Otávio T Nóbrega, Victor M Baião, et al.
BMJ (Clinical Research Ed.)|January 21, 2021
Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trialViviane C Veiga, João A G G Prats, Danielle L C Farias, et al.
Pageof 34

Showing results (311-320 of 333) with videos related to

Sort By:
Pageof 34
Critical Care Medicine|February 21, 2025
Society of Critical Care Medicine Guidelines on Family-Centered Care for Adult ICUs: 2024David Y Hwang, Simon J W Oczkowski, Kimberley Lewis, et al.
The European Respiratory Journal|July 10, 2021
Convalescent plasma for COVID-19 in hospitalised patients: an open-label, randomised clinical trialLeo Sekine, Beatriz Arns, Bruna R Fabro, et al.
Critical Care Explorations|June 26, 2025
Unmet Nonmedication Needs After Hospital Discharge and Adverse Outcomes Among Acute Respiratory Failure Survivors in Brazil: A Prospective Feasibility StudySérgio R R Decker, Danielle do A Pereira, Gabriela S Rech, et al.
The American Journal of Cardiology|December 17, 2023
Cardiovascular Safety of Azithromycin in Patients Hospitalized With COVID-19: A Prespecified Pooled Analysis of the COALITION I and COALITION II Randomized Clinical TrialsRemo H M Furtado, Pedro G M Barros E Silva, Henrique A R Fonseca, et al.
Journal of Critical Care|August 3, 2024
Antisense therapy to block the Kallikrein-kinin pathway in COVID-19: The ASKCOV randomized controlled trialFernando G Zampieri, Glauco Adrieno Westphal, Maria Adelaide Dos Santos, et al.
Eclinicalmedicine|May 24, 2023
Rivaroxaban to prevent major clinical outcomes in non-hospitalised patients with COVID-19: the CARE - COALITION VIII randomised clinical trialÁlvaro Avezum, Haliton Alves Oliveira Junior, Precil Diego M M Neves, et al.
Lancet (London, England)|September 8, 2020
Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trialRemo H M Furtado, Otavio Berwanger, Henrique A Fonseca, et al.
JAMA|September 3, 2020
Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical TrialBruno M Tomazini, Israel S Maia, Alexandre B Cavalcanti, et al.
Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition|October 15, 2024
Agreement between the EWGSOP2 and SDOC consensuses for sarcopenia in patients receiving hemodialysis: Findings of a cross sectional analysis from the SARC-HD studyMarvery P Duarte, Otávio T Nóbrega, Victor M Baião, et al.
BMJ (Clinical Research Ed.)|January 21, 2021
Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trialViviane C Veiga, João A G G Prats, Danielle L C Farias, et al.
Pageof 34